Načítá se...
Extended-Duration Dosing and Distribution of Dalbavancin into Bone and Articular Tissue
Dalbavancin is an intravenous lipoglycopeptide with activity against Gram-positive pathogens and an MIC(90) for Staphylococcus aureus of 0.06 μg/ml. With a terminal half-life of >14 days, dosing regimens with infrequent parenteral administration become available to treat infectious diseases such...
Uloženo v:
| Vydáno v: | Antimicrob Agents Chemother |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society for Microbiology
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4356775/ https://ncbi.nlm.nih.gov/pubmed/25561338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.04550-14 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|